Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RSMDF) FCF Margin (2016 - 2025)

Historic FCF Margin for Resmed (RSMDF) over the last 17 years, with Q4 2025 value amounting to 21.87%.

  • Resmed's FCF Margin fell 5900.0% to 21.87% in Q4 2025 from the same period last year, while for Dec 2025 it was 33.19%, marking a year-over-year increase of 49400.0%. This contributed to the annual value of 32.29% for FY2025, which is 45000.0% up from last year.
  • Latest data reveals that Resmed reported FCF Margin of 21.87% as of Q4 2025, which was down 5900.0% from 31.02% recorded in Q3 2025.
  • Resmed's FCF Margin's 5-year high stood at 43.19% during Q1 2025, with a 5-year trough of 10.29% in Q3 2021.
  • Moreover, its 5-year median value for FCF Margin was 22.28% (2024), whereas its average is 20.66%.
  • Per our database at Business Quant, Resmed's FCF Margin plummeted by -276400bps in 2021 and then skyrocketed by 216000bps in 2023.
  • Resmed's FCF Margin (Quarter) stood at 21.17% in 2021, then crashed by -54bps to 9.8% in 2022, then soared by 119bps to 21.46% in 2023, then rose by 5bps to 22.46% in 2024, then dropped by -3bps to 21.87% in 2025.
  • Its last three reported values are 21.87% in Q4 2025, 31.02% for Q3 2025, and 37.7% during Q2 2025.